Position in VTRS
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$3,138,940
-$76,895 QoQ
Shares Held
232,342
-10.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 83.25786986425183.ToString("F0")%
Shared 0.ToString("F0")%
None 16.742130135748166.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sterling Capital Management LLC holds $21,914,421 across 40 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
450,992 | $13,583,878 | |
| 2 | VTRS |
Viatris Inc
This page
|
232,342 | $3,138,940 | |
| 3 | ZTS |
Zoetis Inc.
|
8,983 | $1,061,880 | |
| 4 | HLN |
Haleon plc
|
94,183 | $942,771 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,429 | $847,368 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
16,596 | $397,142 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
22,625 | $281,228 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
11,270 | $254,702 |
All Filings in VTRS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,138,940 | 232,342 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,215,835 | 258,300 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $986,584 | 99,655 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $946,803 | 106,025 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $810,604 | 93,066 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,212,941 | 97,425 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,818,927 | 156,669 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||